References
- Taylor DP, Carter RB, Eison AS, Mullins UL, Smith HL, Torrente JR, Wright RN, Yocca FD. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. J Clin Psychiatry 1995; 56(suppl 6)3–11
- Cohn CK, Robinson DS, Roberts DL, Schwiderski UE, O'Brien K, Ieni JR. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression. J Clin Psychiatry 1996; 57(suppl 2)15–18
- Robinson DS, Roberts DL, Smith JM, Stringfellow JC, Kaplita SB, Seminara JA, Marcus RN. The safety profile of nefazodone. J Clin Psychiatry 1996; 57(suppl 2)31–38
- D'Mello DA, Meland R, Ransom S. Nefazodone and hypotension: complication or coincidence. J Clin Psychopharmacol 1997; 17(2)136
- Benson BE, Mathiason M, Dahl B, Smith K, Foley MM, Easom LAJ, Butler AY. Toxicities and outcomes associated with nefazodone poisoning: an analysis of 1,338 exposures. Am J Emerg Med 2000; 18(5)586–592
- Catalano G, Catalano MC, Tumarkin NBB. Nefazodone overdose: a case report. Clin Neuropharmacol 1999; 22(1)63–65
- Mackay FJ, Pearce GL, Freemantle SN, Mann RD. Nefazodone in community use: the results of prescription-event monitoring. Pharmacoepidemiol Drug Saf 1999; 8: 267–273
- Gaffney PN, Schuckman HA. Nefazodone overdose. Ann Pharmacother 1998; 32(11)1249–1250
- Yapp P, Ilett KF, Kristensen JH, Hackett LP, Paech MJ, Rampono J. Drowsiness and poor feeding in a breast-fed infant: association with nefazodone and its metabolites. Ann Pharmacother 2000; 34(11)1269–1272
- Anderson W. Antidepressant. Principles of Forensic Toxicology, B Levine. American Association of Clinical Chemistry, Chapel Hill 1999
- , Nefazodone. Dollery, C, Therapeutic Drugs CD-ROM Database (1.0), 1999. Churchill Livingstone.
- Barbhaiya RH, Shukla UA, Greene DS. Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment. Eur J Clin Pharmacol 1995; 49(3)221–228
- Kaul S, Shukla UA, Barbhaiya RH. Nonlinear pharmacokinetics of nefazodone after escalating single and multiple oral doses. J Clin Pharmacol 1995; 35(8)830–839
- Isbister GK, Dawson AH, Whyte IM. Comment: serotonin syndrome induced by fluvoxamine and mirtazapine. Ann Pharmacother 2001; 35(12)1674–1675